رجوع
نطاق اليوم
KWD 23.60
KWD 24.41
نطاق 52 أسبوعًا
KWD 8.58
KWD 25.44
حجم التداول
1,100,986
متوسط 50 يوم / 200 يوم
KWD 21.50
/
KWD 16.47
الإغلاق السابق
KWD 24.09
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -7.4 | 0.3 |
| P/B | 32.8 | 2.9 |
| ROE % | -161.8 | 3.7 |
| Net Margin % | -165.6 | 3.8 |
| Rev Growth 5Y % | 5.4 | 10.0 |
| D/E | 5.4 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 39.330
+63.7%
Low: KWD 35.000
High: KWD 45.000
ربحية السهم المستقبلية
-KWD 1.588
الإيرادات المقدّرة
370 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 3.408
KWD 2.440 – KWD 4.615
|
1.1 B | 5 |
| FY2029 |
KWD 2.418
KWD 1.731 – KWD 3.274
|
910 M | 2 |
| FY2028 |
KWD 1.025
-KWD 0.009 – KWD 2.326
|
760 M | 7 |
النقاط الرئيسية
Revenue grew 5.39% annually over 5 years — modest growth
Debt/Equity of 5.36 — high leverage
Negative free cash flow of -323.17M
PEG of 0.55 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 622.45%
Capital efficient — spends only 0.11% of revenue on capex
النمو
Revenue Growth (5Y)
5.39%
Revenue (1Y)627.84%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-161.82%
ROIC-49.82%
Net Margin-165.60%
Op. Margin-158.45%
الأمان
Debt / Equity
5.36
Current Ratio4.40
Interest Coverage-8.08
التقييم
P/E Ratio
-7.42
P/B Ratio32.78
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 627.84% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 5.39% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 172.35M | Net Income (TTM) | -285.42M |
| ROE | -161.82% | ROA | -53.88% |
| Gross Margin | 95.96% | Operating Margin | -158.45% |
| Net Margin | -165.60% | Free Cash Flow (TTM) | -323.17M |
| ROIC | -49.82% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 5.36 | Current Ratio | 4.40 |
| Interest Coverage | -8.08 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -7.42 | P/B Ratio | 32.78 |
| P/S Ratio | 12.29 | PEG Ratio | 0.55 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.12B | Enterprise Value | 2.33B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 172.35M | 23.68M | 0.0 | 0.0 | 139.71M |
| Net Income | -285.42M | -318.76M | -209.36M | -149.34M | 24.93M |
| EPS (Diluted) | -3.30 | -3.73 | -2.98 | -2.46 | 0.48 |
| Gross Profit | 165.38M | 22.85M | 0.0 | 0.0 | 139.71M |
| Operating Income | -273.08M | -339.67M | -229.95M | -151.76M | 26.22M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 529.71M | 724.82M | 612.88M | 497.24M | 449.66M |
| Total Liabilities | 465.08M | 436.69M | 58.68M | 29.79M | 41.29M |
| Shareholders' Equity | 64.63M | 288.12M | 554.20M | 467.45M | 408.37M |
| Total Debt | 346.48M | 345.74M | 1.64M | 1.16M | 20.97M |
| Cash & Equivalents | 134.93M | 154.08M | 295.39M | 74.36M | 221.97M |
| Current Assets | 528.08M | 603.06M | 580.88M | 489.79M | 448.40M |
| Current Liabilities | 120.12M | 103.55M | 58.10M | 29.07M | 20.68M |